GYKI-52466: A potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy
Gespeichert in:
| Veröffentlicht in: | Medical hypotheses 2010-03, Vol.74 (3), p.619-620 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 620 |
|---|---|
| container_issue | 3 |
| container_start_page | 619 |
| container_title | Medical hypotheses |
| container_volume | 74 |
| creator | Nandhu, M.S Paul, Jes Mathew, Jobin Peeyush Kumar, T Paulose, C.S |
| description | |
| doi_str_mv | 10.1016/j.mehy.2009.10.033 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733953333</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0306987709007129</els_id><sourcerecordid>733953333</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-d973d216c75477c01fc5023ffc1e5ac0134e63555bbdfac771e960e3c2c526fd3</originalsourceid><addsrcrecordid>eNp9UU1r3DAUFKWl2WzyB3oovvXkrT4sKSohsCz5ooEWmh56Elr5OZFrWxtJLvG_j5xdKPTQdxneMDPw5iH0geAVwUR8blc9PE4rirHKxAoz9gYtCGe0pFLKt2iBGRalOpPyCB3H2OIsrNjZe3RElCJV3hYIrn99vS05rYT4UqyLnU8wJGe6Ij1CMDsYk7OFechk0fhQPHRjMr1JUPZQu4x1Ac_WJZ_8cxa6oR3DlKHYQIBtyDnfTRenE_SuyQinB1yin1eX95ub8u7b9e1mfVdaJkgqayVZTYmwkldSWkwayzFlTWMJcJN3VoFgnPPttm6MlZKAEhiYpZZT0dRsiT7tc3fBP40Qk-5dtNB1ZgA_Ri0ZU5zNs0R0r7TBxxig0bvgehMmTbCe29WtntvVc7szh19NHw_x4zbf_9dyqDMLzvcCyEf-cRB0tA4Gm7sKYJOuvft__sU_dtu5wVnT_YYJYuvHMOT6NNGRaqx_zP-d34sVxpJQxV4ArLOgHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733953333</pqid></control><display><type>article</type><title>GYKI-52466: A potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Nandhu, M.S ; Paul, Jes ; Mathew, Jobin ; Peeyush Kumar, T ; Paulose, C.S</creator><creatorcontrib>Nandhu, M.S ; Paul, Jes ; Mathew, Jobin ; Peeyush Kumar, T ; Paulose, C.S</creatorcontrib><identifier>ISSN: 0306-9877</identifier><identifier>EISSN: 1532-2777</identifier><identifier>DOI: 10.1016/j.mehy.2009.10.033</identifier><identifier>PMID: 19914009</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Benzodiazepines - administration & dosage ; Brain Diseases - complications ; Brain Diseases - drug therapy ; Brain Diseases - metabolism ; Cerebral Palsy - drug therapy ; Cerebral Palsy - etiology ; Cerebral Palsy - metabolism ; Glutamic Acid - metabolism ; Humans ; Internal Medicine ; Models, Neurological ; Receptors, AMPA - antagonists & inhibitors</subject><ispartof>Medical hypotheses, 2010-03, Vol.74 (3), p.619-620</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c361t-d973d216c75477c01fc5023ffc1e5ac0134e63555bbdfac771e960e3c2c526fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mehy.2009.10.033$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27904,27905,45975</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19914009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nandhu, M.S</creatorcontrib><creatorcontrib>Paul, Jes</creatorcontrib><creatorcontrib>Mathew, Jobin</creatorcontrib><creatorcontrib>Peeyush Kumar, T</creatorcontrib><creatorcontrib>Paulose, C.S</creatorcontrib><title>GYKI-52466: A potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy</title><title>Medical hypotheses</title><addtitle>Med Hypotheses</addtitle><subject>Benzodiazepines - administration & dosage</subject><subject>Brain Diseases - complications</subject><subject>Brain Diseases - drug therapy</subject><subject>Brain Diseases - metabolism</subject><subject>Cerebral Palsy - drug therapy</subject><subject>Cerebral Palsy - etiology</subject><subject>Cerebral Palsy - metabolism</subject><subject>Glutamic Acid - metabolism</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Models, Neurological</subject><subject>Receptors, AMPA - antagonists & inhibitors</subject><issn>0306-9877</issn><issn>1532-2777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1r3DAUFKWl2WzyB3oovvXkrT4sKSohsCz5ooEWmh56Elr5OZFrWxtJLvG_j5xdKPTQdxneMDPw5iH0geAVwUR8blc9PE4rirHKxAoz9gYtCGe0pFLKt2iBGRalOpPyCB3H2OIsrNjZe3RElCJV3hYIrn99vS05rYT4UqyLnU8wJGe6Ij1CMDsYk7OFechk0fhQPHRjMr1JUPZQu4x1Ac_WJZ_8cxa6oR3DlKHYQIBtyDnfTRenE_SuyQinB1yin1eX95ub8u7b9e1mfVdaJkgqayVZTYmwkldSWkwayzFlTWMJcJN3VoFgnPPttm6MlZKAEhiYpZZT0dRsiT7tc3fBP40Qk-5dtNB1ZgA_Ri0ZU5zNs0R0r7TBxxig0bvgehMmTbCe29WtntvVc7szh19NHw_x4zbf_9dyqDMLzvcCyEf-cRB0tA4Gm7sKYJOuvft__sU_dtu5wVnT_YYJYuvHMOT6NNGRaqx_zP-d34sVxpJQxV4ArLOgHg</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Nandhu, M.S</creator><creator>Paul, Jes</creator><creator>Mathew, Jobin</creator><creator>Peeyush Kumar, T</creator><creator>Paulose, C.S</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>GYKI-52466: A potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy</title><author>Nandhu, M.S ; Paul, Jes ; Mathew, Jobin ; Peeyush Kumar, T ; Paulose, C.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-d973d216c75477c01fc5023ffc1e5ac0134e63555bbdfac771e960e3c2c526fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Benzodiazepines - administration & dosage</topic><topic>Brain Diseases - complications</topic><topic>Brain Diseases - drug therapy</topic><topic>Brain Diseases - metabolism</topic><topic>Cerebral Palsy - drug therapy</topic><topic>Cerebral Palsy - etiology</topic><topic>Cerebral Palsy - metabolism</topic><topic>Glutamic Acid - metabolism</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Models, Neurological</topic><topic>Receptors, AMPA - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nandhu, M.S</creatorcontrib><creatorcontrib>Paul, Jes</creatorcontrib><creatorcontrib>Mathew, Jobin</creatorcontrib><creatorcontrib>Peeyush Kumar, T</creatorcontrib><creatorcontrib>Paulose, C.S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical hypotheses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nandhu, M.S</au><au>Paul, Jes</au><au>Mathew, Jobin</au><au>Peeyush Kumar, T</au><au>Paulose, C.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GYKI-52466: A potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy</atitle><jtitle>Medical hypotheses</jtitle><addtitle>Med Hypotheses</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>74</volume><issue>3</issue><spage>619</spage><epage>620</epage><pages>619-620</pages><issn>0306-9877</issn><eissn>1532-2777</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>19914009</pmid><doi>10.1016/j.mehy.2009.10.033</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0306-9877 |
| ispartof | Medical hypotheses, 2010-03, Vol.74 (3), p.619-620 |
| issn | 0306-9877 1532-2777 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733953333 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Benzodiazepines - administration & dosage Brain Diseases - complications Brain Diseases - drug therapy Brain Diseases - metabolism Cerebral Palsy - drug therapy Cerebral Palsy - etiology Cerebral Palsy - metabolism Glutamic Acid - metabolism Humans Internal Medicine Models, Neurological Receptors, AMPA - antagonists & inhibitors |
| title | GYKI-52466: A potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A12%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GYKI-52466:%20A%20potential%20therapeutic%20agent%20for%20glutamate-mediated%20excitotoxic%20injury%20in%20Cerebral%20Palsy&rft.jtitle=Medical%20hypotheses&rft.au=Nandhu,%20M.S&rft.date=2010-03-01&rft.volume=74&rft.issue=3&rft.spage=619&rft.epage=620&rft.pages=619-620&rft.issn=0306-9877&rft.eissn=1532-2777&rft_id=info:doi/10.1016/j.mehy.2009.10.033&rft_dat=%3Cproquest_cross%3E733953333%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733953333&rft_id=info:pmid/19914009&rft_els_id=1_s2_0_S0306987709007129&rfr_iscdi=true |